Right-to-try laws enable terminally ill patients to try experimental treatments that have completed only Phase 1 testing, posing ethical concerns over patient safety and efficacy.
Proponents of right-to-try laws argue that they empower desperate patients to seek treatments that might save their lives, positioning governmental approval as a barrier to hope.
Critics worry that these regulations may exploit vulnerable populations by allowing untested treatments, raising questions about the protection of patients against predatory practices.
The persuasive narrative surrounding right-to-try laws appeals to compassion and freedom but demands a critical analysis to fully understand its implications on patient safety.
Collection
[
|
...
]